ALL-PB:NYE-The Allstate Corporation (USD)

PREFERRED STOCK | |

Last Closing

USD 26.35

Change

0.00 (0.00)%

Market Cap

USD 33.91B

Volume

0.08M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-04 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
TBB AT&T Inc

-0.08 (-0.33%)

USD 141.28B
CCZ Comcast Holdings Corp

N/A

USD 51.92B
PFH Prudential Financial Inc 4.125..

-0.05 (-0.26%)

USD 45.49B
PRS Prudential Financial Inc

+0.02 (+0.08%)

USD 44.13B
SOJC Southern Co

-0.02 (-0.09%)

USD 23.13B
AIO Virtus AllianzGI Artificial In..

+0.25 (+1.27%)

USD 16.20B
AIZN Assurant Inc

-0.16 (-0.76%)

USD 9.38B
RZB Reinsurance Group of America I..

-0.15 (-0.59%)

USD 8.83B
PCG-PA Pacific Gas and Electric Compa..

N/A

USD 6.07B
UNMA Unum Group

-0.04 (-0.16%)

USD 5.66B

ETFs Containing ALL-PB

N/A

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.81% N/A N/A 64% D
Dividend Return 1.27% N/A N/A 54% F
Total Return 6.08% N/A N/A 65% D
Trailing 12 Months  
Capital Gain 4.81% N/A N/A 46% F
Dividend Return 1.27% N/A N/A 16% F
Total Return 6.08% N/A N/A 39% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -0.49% N/A N/A 37% F
Dividend Return 0.06% N/A N/A 27% F
Total Return 0.55% N/A N/A 13% F
Risk Return Profile  
Volatility (Standard Deviation) 5.49% N/A N/A 90% A-
Risk Adjusted Return 1.13% N/A N/A 28% F
Market Capitalization 33.91B N/A N/A 93% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:

There is nothing we particularly dislike